We use cookies to collect anonymous data to help us improve your site browsing
experience.
Click 'Accept all cookies' to agree to all cookies that collect anonymous data.
To only allow the cookies that make the site work, click 'Use essential cookies only.' Visit 'Set cookie preferences' to control specific cookies.
Business and Regulatory Impact Assessment (BRIA) exploring the costs and benefits associated with the move to a soft opt out system of organ and tissue donation.